Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1.

Tenno M, Kézdy FJ, Elhammer AP, Kurosaka A.

Biochem Biophys Res Commun. 2002 Nov 15;298(5):755-9.

PMID:
12419318
2.

The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sites.

Tenno M, Saeki A, Kézdy FJ, Elhammer AP, Kurosaka A.

J Biol Chem. 2002 Dec 6;277(49):47088-96. Epub 2002 Oct 2.

3.

An efficient assay for dolichyl phosphate-mannose: protein O-mannosyltransferase.

Hendershot LL, Aeed PA, Kézdy FJ, Elhammer AP.

Anal Biochem. 2002 Aug 15;307(2):273-9.

PMID:
12202244
4.
5.

The acceptor specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.

Elhammer AP, Kézdy FJ, Kurosaka A.

Glycoconj J. 1999 Feb;16(2):171-80. Review.

PMID:
10612416
6.

The pretransition of dipalmitoyllecithin bilayers as probed by the fluorescent pyrrolopyrimidine, U-104067.

Epps DE, Wilson CL, Vosters AF, Kézdy FJ.

Chem Phys Lipids. 1997 Apr 25;86(2):121-33.

PMID:
9179994
7.

A scintillation proximity assay for UDP-GalNAc:polypeptide, N-acetylgalactosaminyltransferase.

Baker CA, Poorman RA, Kézdy FJ, Staples DJ, Smith CW, Elhammer AP.

Anal Biochem. 1996 Jul 15;239(1):20-4.

PMID:
8660620
8.

Novenamines as inhibitors of two independent enzymes during DNA replication in a toluenized Escherichia coli cell system.

Althaus IW, Kézdy FJ, Peterson T, Spilman CH, Reusser F.

Biochem Pharmacol. 1996 May 17;51(10):1373-8.

PMID:
8787554
9.

The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.

Althaus IW, Franks KM, Langley KB, Kézdy FJ, Peterson T, Buxser SE, Decker DE, Dolak LA, Ulrich RG, Reusser F.

Experientia. 1996 Apr 15;52(4):329-35.

PMID:
8620935
10.

The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.

Althaus IW, Chou KC, Lemay RJ, Franks KM, Deibel MR, Kezdy FJ, Resnick L, Busso ME, So AG, Downey KM, Romero DL, Thomas RC, Aristoff PA, Tarpley WG, Reusser F.

Biochem Pharmacol. 1996 Mar 22;51(6):743-50.

PMID:
8602869
11.

Kinetics and inhibition of lipid exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein).

Epps DE, Greenlee KA, Harris JS, Thomas EW, Castle CK, Fisher JF, Hozak RR, Marschke CK, Melchior GW, Kézdy FJ.

Biochemistry. 1995 Oct 3;34(39):12560-9.

PMID:
7548004
12.

Evidence that cynomolgus monkey cholesteryl ester transfer protein has two neutral lipid binding sites.

Melchior GW, Greenlee KA, Castle CK, Prough MJ, Milne RW, Marotti KR, Kezdy FJ.

J Biol Chem. 1995 Sep 8;270(36):21068-74.

13.

Method for measuring the activities of cholesteryl ester transfer protein (lipid transfer protein).

Epps DE, Harris JS, Greenlee KA, Fisher JF, Marschke CK, Castle CK, Ulrich RG, Moll TS, Melchior GW, Kézdy FJ.

Chem Phys Lipids. 1995 Aug 1;77(1):51-63.

PMID:
7586092
14.
15.

Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes.

Harris JS, Epps DE, Davio SR, Kézdy FJ.

Biochemistry. 1995 Mar 21;34(11):3851-7.

PMID:
7893682
16.

A vector projection method for predicting the specificity of GalNAc-transferase.

Chou KC, Zhang CT, Kézdy FJ, Poorman RA.

Proteins. 1995 Feb;21(2):118-26.

PMID:
7777486
17.

Kinetics of processive nucleic acid polymerases and nucleases.

Chou KC, Kézdy FJ, Reusser F.

Anal Biochem. 1994 Sep;221(2):217-30. Review. No abstract available.

PMID:
7529005
18.

Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152E.

Althaus IW, Chou JJ, Gonzales AJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Thomas RC, Aristoff PA, Tarpley WG, et al.

Biochem Pharmacol. 1994 Jun 1;47(11):2017-28.

PMID:
7516658
19.

The efficiency and kinetics of secretion of apolipoprotein A-I in hepatic and non-hepatic cells.

LeCureux LW, Kezdy FJ, Wattenberg BW.

Atherosclerosis. 1994 Apr;106(2):225-33.

PMID:
8060382
20.

Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor.

Althaus IW, Chou JJ, Gonzales AJ, LeMay RJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Thomas RC, Aristoff PA, et al.

Experientia. 1994 Jan 15;50(1):23-8.

21.

The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase.

Althaus IW, Gonzales AJ, Chou JJ, Romero DL, Deibel MR, Chou KC, Kezdy FJ, Resnick L, Busso ME, So AG, et al.

J Biol Chem. 1993 Jul 15;268(20):14875-80.

22.

Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E.

Althaus IW, Chou JJ, Gonzales AJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Palmer JR, Thomas RC, Aristoff PA, et al.

Biochemistry. 1993 Jul 6;32(26):6548-54.

PMID:
7687145
23.

A vector projection approach to predicting HIV protease cleavage sites in proteins.

Chou KC, Zhang CT, Kézdy FJ.

Proteins. 1993 Jun;16(2):195-204.

PMID:
8332607
24.
25.

Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.

Althaus IW, Chou JJ, Gonzales AJ, Deibel MR, Chou KC, Kezdy FJ, Romero DL, Aristoff PA, Tarpley WG, Reusser F.

J Biol Chem. 1993 Mar 25;268(9):6119-24.

26.

Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.

Evans DB, Kézdy FJ, Tarpley G, Sharma SK.

Biotechnol Appl Biochem. 1993 Feb;17(1):91-102.

PMID:
7679907
27.

Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.

Althaus IW, LeMay RJ, Gonzales AJ, Deibel MR, Sharma SK, Kezdy FJ, Resnick L, Busso ME, Aristoff PA, Reusser F.

Experientia. 1992 Dec 1;48(11-12):1127-32.

PMID:
1282106
28.

pH dependence of kinetic parameters of pepsin, rhizopuspepsin, and their active-site hydrogen bond mutants.

Lin Y, Fusek M, Lin X, Hartsuck JA, Kezdy FJ, Tang J.

J Biol Chem. 1992 Sep 15;267(26):18413-8.

29.

Interaction of antioxidants with depth-dependent fluorescence quenchers and energy transfer probes in lipid bilayers.

Hinzmann JS, McKenna RL, Pierson TS, Han F, Kezdy FJ, Epps DE.

Chem Phys Lipids. 1992 Sep;62(2):123-38.

PMID:
1423807
30.

The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.

Dueweke TJ, Kézdy FJ, Waszak GA, Deibel MR Jr, Tarpley WG.

J Biol Chem. 1992 Jan 5;267(1):27-30.

31.
32.

Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide.

Zhang ZY, Poorman RA, Maggiora LL, Heinrikson RL, Kézdy FJ.

J Biol Chem. 1991 Aug 25;266(24):15591-4.

33.
35.

Synapsin I is a highly surface-active molecule.

Ho MF, Bähler M, Czernik AJ, Schiebler W, Kézdy FJ, Kaiser ET, Greengard P.

J Biol Chem. 1991 Mar 25;266(9):5600-7.

36.
37.

Chromogenic substrates and assay of phospholipases A2.

Cho W, Kézdy FJ.

Methods Enzymol. 1991;197:75-9. No abstract available.

PMID:
2051947
38.

Production of an antibody to arterial fatty acid-binding protein (FABP) using a synthetic peptide as the antigen.

St John LC, Bell FP, Kezdy FJ, Vosters A, Sharma SK, Kinner JH, Smith CW.

Comp Biochem Physiol B. 1991;99(2):431-5.

PMID:
1764924
39.
40.
41.

Sequence analysis of bovine lens aldose reductase.

Schade SZ, Early SL, Williams TR, Kézdy FJ, Heinrikson RL, Grimshaw CE, Doughty CC.

J Biol Chem. 1990 Mar 5;265(7):3628-35.

42.
43.

Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology.

Kaumaya PT, Berndt KD, Heidorn DB, Trewhella J, Kezdy FJ, Goldberg E.

Biochemistry. 1990 Jan 9;29(1):13-23. Erratum in: Biochemistry 1990 Aug 21;29(33):7780.

PMID:
1691014
44.

A novel bifunctional mechanism of surface recognition by phospholipase A2.

Heinrikson RL, Kézdy FJ.

Adv Exp Med Biol. 1990;279:37-47. Review. No abstract available.

PMID:
2096699
45.

Dimerization and activation of porcine pancreatic phospholipase A2 via substrate level acylation of lysine 56.

Tomasselli AG, Hui J, Fisher J, Zürcher-Neely H, Reardon IM, Oriaku E, Kézdy FJ, Heinrikson RL.

J Biol Chem. 1989 Jun 15;264(17):10041-7.

46.

An activation-collision mechanism for cholesterol transfer between membranes.

Steck TL, Kezdy FJ, Lange Y.

J Biol Chem. 1988 Sep 15;263(26):13023-31.

47.
48.

Identification of the active-site serine in human lecithin: cholesterol acyltransferase.

Farooqui JZ, Wohl RC, Kézdy FJ, Scanu AM.

Arch Biochem Biophys. 1988 Mar;261(2):330-5.

PMID:
3128170
49.

Evidence that uncharged verapamil inhibits myocardial contractility.

Cohen L, Vereault D, Wasserstrom JA, Retzinger GS, Kezdy FJ.

J Pharmacol Exp Ther. 1987 Aug;242(2):721-5.

PMID:
3612559
50.

Peptides with affinity for membranes.

Kaiser ET, Kézdy FJ.

Annu Rev Biophys Biophys Chem. 1987;16:561-81. Review. No abstract available.

PMID:
3297092

Supplemental Content

Support Center